Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 5,705 | 0.0% | 95,997 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 5,010 | 0.0% | 92,497 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 5,085 | 0.0% | 92,497 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 6,539 | 0.0% | 92,497 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 6,155 | 0.0% | 93,645 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 6,906 | 0.0% | 98,245 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 24,664 | 0.0% | 299,579 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 25,944 | 0.0% | 297,049 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 30,347 | 0.0% | 314,739 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 29,311 | 0.0% | 331,276 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 26,198 | 0.0% | 302,233 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 29,633 | 0.0% | 304,738 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 32,842 | 0.0% | 317,345 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 32,405 | 0.0% | 382,267 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 32,085 | 0.0% | 387,171 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 30,571 | 0.0% | 396,509 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 24,955 | 0.0% | 282,461 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 21,548 | 0.0% | 278,788 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 35,346 | 0.0% | 423,614 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 32,012 | 0.0% | 423,939 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 40,065 | 0.0% | 456,890 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 36,997 | 0.0% | 486,290 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 54,122 | 0.1% | 438,803 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 35,785 | 0.1% | 423,487 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 33,743 | 0.0% | 399,089 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 3,254 | 0.0% | 52,300 | 6/30/2014 |
| 2014 Q1 | 5/5/2014 | 7,292 | 0.0% | 106,900 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 7,512 | 0.0% | 106,900 | 12/31/2013 |